Dowling & Yahnke LLC Geron Corp Transaction History
Dowling & Yahnke LLC
- $215 Million
- Q3 2022
A detailed history of Dowling & Yahnke LLC transactions in Geron Corp stock. As of the latest transaction made, Dowling & Yahnke LLC holds 39,047 shares of GERN stock, worth $49,589. This represents 0.04% of its overall portfolio holdings.
Number of Shares
39,047
Previous 39,047
-0.0%
Holding current value
$49,589
Previous $61,000
49.18%
% of portfolio
0.04%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding GERN
# of Institutions
282Shares Held
509MCall Options Held
884KPut Options Held
564K-
Ra Capital Management, L.P. Boston, MA60.4MShares$76.7 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$59.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$54.6 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA35.6MShares$45.2 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$34.6 Million8.13% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $480M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...